Is there any possibility of fertility-sparing surgery in patients with clear-cell carcinoma of the ovary?

Gynecologic Oncology

Volumn 111, Issue 3, 2008, Pages 523-526

  Kajiyama, Hiroaki ^a   Shibata, Kiyosumi ^a   Suzuki, Shiro ^a   Ino, Kazuhiko ^a   Yamamoto, Eiko ^a   Mizuno, Kimio ^b   Sakakibara, Katsumi ^c   Matsuzawa, Katsuji ^d   Takeda, Akihiro ^e   Kinoshita, Yoshito ^f   Kawai, Michiyasu ^g   Nagasaka, Tetsuro ^h   Nawa, Akihiro ^a   Kikkawa, Fumitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^c Okazaki City Hospital   (Japan)

^d ANJO KOSEI HOSPITAL   (Japan)

^e GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^f OGAKI MUNICIPAL HOSPITAL   (Japan)

^g TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

^h NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Clear cell carcinoma of the ovary (CCC); Clinical outcome; Fertility sparing surgery; Pregnancy

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; PACLITAXEL;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; FEMALE; FERTILITY; FERTILITY SPARING SURGERY; HUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; SURGICAL APPROACH; TREATMENT OUTCOME;

ADENOCARCINOMA, CLEAR CELL; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; FERTILITY; FOLLOW-UP STUDIES; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS;

EID: 56449098764     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.04.001     Document Type: Article

References (18)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer statistics, 2001. CA Cancer J Clin 51 (2001) 15-36
2. Morice P., Leblanc E., Rey A., Baron M., Querleu D., Blanchot J., et al. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Societe Francaise d'Oncologie Gynecologique). Hum Reprod 20 (2005) 1379-1385
3. Duska L.R., Chang Y.C., Flynn C.E., Chen A.H., Goodman A., Fuller A.F., et al. Epithelial ovarian carcinoma in the reproductive age group. Cancer 85 (1999) 2623-2629
4. Plaxe S.C., Braly P.S., Freddo J.L., McClay E., Kirmani S., and Howell S.B. Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancer. Obstet Gynecol 81 (1993) 651-654
5. Rodriguez M., Nguyen H.N., Averette H.E., Steren A.J., Penalver M.A., Harrison T., et al. National survey of ovarian carcinoma XII. Epithelial ovarian malignancies in women less than or equal to 25 years of age. Cancer 73 (1994) 1245-1250
6. Swenerton K.D., Hislop T.G., Spinelli J., LeRiche J.C., Yang N., and Boyes D.A. Ovarian carcinoma: a multivariate analysis of prognostic factors. Obstet Gynecol 65 (1985) 264-270
7. Smedley H., and Sikora K. Age as a prognostic factor in epithelial ovarian carcinoma. Br J Obstet Gynaecol 92 (1985) 839-842
8. In: Serov S.F.S.R., and Sobin L.H. (Eds). International histologic classification of tumors. Vol. 9 (1973), World Health Organization, Geneva Vol.
9. Kennedy A.W., Biscotti C.V., Hart W.R., and Webster K.D. Ovarian clear cell adenocarcinoma. Gynecol Oncol 32 (1989) 342-349
10. Goff B.A., Sainz de la Cuesta R., Muntz H.G., Fleischhacker D., Ek M., Rice L.W., et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol 60 (1996) 412-417
11. Czernobilsky B., Silverman B.B., and Enterline H.T. Clear-cell carcinoma of the ovary. A clinicopathologic analysis of pure and mixed forms and comparison with endometrioid carcinoma. Cancer 25 (1970) 762-772
12. Matsuura Y., Robertson G., Marsden D.E., Kim S.N., Gebski V., and Hacker N.F. Thromboembolic complications in patients with clear cell carcinoma of the ovary. Gynecol Oncol 104 (2007) 406-410
13. Sugiyama T., Kamura T., Kigawa J., Terakawa N., Kikuchi Y., Kita T., et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 88 (2000) 2584-2589
14. O'Brien M.E., Schofield J.B., Tan S., Fryatt I., Fisher C., and Wiltshaw E. Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages. Gynecol Oncol 49 (1993) 250-254
15. Omura G.A., Brady M.F., Homesley H.D., Yordan E., Major F.J., Buchsbaum H.J., et al. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol 9 (1991) 1138-1150
16. Schilder J.M., Thompson A.M., DePriest P.D., Ueland F.R., Cibull M.L., Kryscio R.J., et al. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol 87 (2002) 1-7
17. Eitan R., and Chi D.S. Successful pregnancies following fertility-preserving treatment for ovarian carcinoma. Nat Clin Pract Oncol 2 (2005) 647-651 quiz 652
18. Trimbos J.B., Parmar M., Vergote I., Guthrie D., Bolis G., Colombo N., et al. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 95 (2003) 105-112